Pneumocystis jiroveci Pneumonia in Inflammatory Bowel Disease Patients: A Survey of Prophylaxis Patterns among Gastroenterology Providers

被引：0
|
作者：
Okafor, Philip [1 ]
Wasan, Sharmeel [1 ]
Farraye, Francis [1 ]
机构：
[1] Boston Med Ctr, Gastroenterol Sect, Boston, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2012年 / 107卷
关键词：
D O I：
10.14309/00000434-201210001-01603
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1603
引用
收藏
页码：S647 / S648
页数：2
相关论文
共 50 条
  • [41] Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease
    Long, Millie D.
    Martin, Christopher F.
    Sandler, Robert S.
    Kappelman, Michael
    GASTROENTEROLOGY, 2012, 142 (05) : S786 - S786
  • [42] Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?
    Bernasko, Nana
    Clarke, Kofi
    CROHNS & COLITIS 360, 2021, 3 (04)
  • [43] Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease
    Kimura, Miho
    Tanaka, Sumiaki
    Ishikawa, Akira
    Endo, Hirahito
    Hirohata, Shunsei
    Kondo, Hirobumi
    RHEUMATOLOGY INTERNATIONAL, 2008, 28 (07) : 673 - 676
  • [44] Suggested guidelines for Pneumocystis jiroveci pneumonia prophylaxis in patients treated with systemic immunosuppressive agents for dermatologic conditions
    Santiago, Tania M. Gonzalez
    Wetter, David
    Kalaaji, Amer
    Lehman, Julia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB63 - AB63
  • [45] Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative Patients
    Fillatre, Pierre
    Decaux, Olivier
    Jouneau, Stephane
    Revest, Matthieu
    Gacouin, Arnaud
    Robert-Gangneux, Florence
    Fresnel, Annie
    Guiguen, Claude
    Le Tulzo, Yves
    Jego, Patrick
    Tattevin, Pierre
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (12): : 1242.e11 - 1242.e17
  • [46] CHOICE OF PNEUMOCYSTIS JIROVECI PNEUMONIA PROPHYLAXIS DOES NOT INCREASE HEMATOLOGIC TOXICITY OF TEMOZOLOMIDE AND RADIATION IN PATIENTS WITH GLIOBLASTOMA
    Streeter, Jessica C.
    Cohen, Adam
    Gilreath, Jeffrey
    Sageser, Daniel
    Ye, Xiangyang
    NEURO-ONCOLOGY, 2012, 14 : 72 - 72
  • [47] Pneumocystis jiroveci Dihydropteroate Synthase Gene Mutations Among Colonized Individuals and Pneumocystis Pneumonia Patients From Spain
    Friaza, Vicente
    Morilla, Ruben
    Respaldiza, Nieves
    de la Horra, Carmen
    Calderon, Enrique J.
    POSTGRADUATE MEDICINE, 2010, 122 (06) : 24 - 28
  • [48] Pneumocystis Jiroveci Pneumonia in Immunocompromised Patients with Rheumatologic Disease in a Single, Tertiary Medical Center
    Rehman, Zahra
    Krause, Megan
    Newman, Jessica
    Bhadbhade, Pooja
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [49] Biosimilars for Pediatric Patients With Inflammatory Bowel Disease: Pediatric Gastroenterology Clinical Practice Survey
    Maltz, Ross M.
    McClinchie, Madeline G.
    Boyle, Brendan M.
    McNicol, Megan
    Morris, Grant A.
    Crawford, Erin C.
    Moses, Jonathan
    Kim, Sandra C.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 76 (05): : 616 - 621
  • [50] FREQUENCY OF VACCINATION FOR PNEUMONIA AMONG INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS
    Trivedi, Chinmay
    Kavani, Himanshu
    Khan, Nabeel H.
    GASTROENTEROLOGY, 2018, 154 (06) : S801 - S802
12345